Navigation Links
Its All In The Genes

Recent research has revealed that a person’s genes determine his propensity towards being an entrepreneur or being self-employed//.

Professor Tim Spector of St Thomas' Hospital in London.and scientists at Imperial College, London and Case Western Reserve University in Cleveland conducted the research and came to the conclusion that family environment and upbringing had very little impact upon entrepreneurs.

The subjects of the study were 609 pairs of identical twins who share exactly the same genes and 657 pairs of same-sex, non-identical twins in the UK. The scientists considered whether entrepreneurship was more common among identical twins, suggesting a genetic influence.

The results of the research revealed that if a pair of twins were identical the chances of them both being self-employed was higher than if they were non-identical. ‘This relatively high heritability suggests the importance of considering genetic factors to explain why some people are entrepreneurial, while others are not,’ said Spector.

’Evidence has shown that genetic factors influence a variety of business-related areas from job satisfaction to vocational interests and work values,’ he said.

The findings of the research were presented at a meeting at the London Business School. The role of genes on personality traits and abilities that influence people to become entrepreneurs were highlighted there.

Professor Tim Spector, the director of the Twin Research Unit at St Thomas's Hospital, London, said: ‘The research is important for business schools and employers who, in the future could, identify ways of selecting those who were most likely to succeed.’

Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Genes for lung disease
3. Genesis of SUPAC
4. Genes for Vision discovered
5. Genes Found To Help Leukemia Treatment
6. Cardiac Valve Disease Linked To Genes
7. Genes Linked To Cigarette Addiction
8. Genes from saliva may predict oral and breast cancer
9. Genes More Important Than Exercise for Bad Cholesterol
10. Genes responsible for social behavior of us
11. Genes to Extend Longevity Discovered
Post Your Comments:

(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: